HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Clinical trials for HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA explained in plain language.
Never miss a new study
Get alerted when new HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA trials appear
Sign up with your email to follow new studies for HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for rare, severe high cholesterol
Disease control CompletedThis study tested a new medicine called SHR-1918 in 26 people with a rare genetic condition that causes extremely high cholesterol (homozygous familial hypercholesterolemia). The main goal was to see if the drug could lower their bad cholesterol levels after 12 weeks. All partici…
Matched conditions: HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Phase: PHASE2 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 17, 2026 08:54 UTC
-
New drug shows promise for rare cholesterol disease
Disease control CompletedThis study tested a new medicine called SHR-1918 in 55 people with homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing very high cholesterol. The goal was to see if the drug could safely lower bad cholesterol levels. Participants received either the …
Matched conditions: HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Phase: PHASE3 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 11, 2026 20:38 UTC